@SPARCIBD

SPARC IBD—Study of a Prospective Adult Research Cohort with IBD—is a multicentered longitudinal study of adult IBD patients.

crohnscolitisfoundation.org/research/current-research-initiatives/sparc-ibd
Joined May 2023
  • Tweets15
  • Following18
  • Followers49
As part of #CCAwarenessWeek, we are making #IBDvisible by demystifying diet & nutrition. View educational resources about diet & nutrition, including Gut Friendly Recipes, which includes over 500 recipes vetted by dietitians who specialize in IBD, here: bit.ly/3Thaptg
14
1
27
2,804
The Microbiome in Quiescent Crohn’s Disease with Persistent Symptoms S... sciencedirect.com/science/ar…
1
80
Are you ready to make #IBDVisible? See all of the ways you can get involved in #CCAwarenessWeek here: bit.ly/3g2iLiV
8
1
22
3,313
Extra-Intestinal Manifestations of Inflammatory Bowel Disease are Associated with Increased Biologic Cycling | Crohn's & Colitis 360 academic.oup.com/crohnscolit…

Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic...

AbstractBackground. Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are a common, frequently debilitating complication of the dis

academic.oup.com
1
1
60
Dynamics of the Gut Mycobiome in Patients with Ulcerative Colitis - Clinical Gastroenterology and Hepatology (cghjournal.org)
1
63
SPARC IBD Study retweeted
Shrinivas Bishu@IBDimmunology9 Sep 2023
study by my talented colleague @ryanungaro in @AGA_CGH ✅UST > VDZ after aTNF in 2 seperate cohorts (@MSHS_IBDCenter, @SPARCIBD) I’m excited cause…This study used data from @SPARCIBD @CrohnsColitisFn Check @SPARCIBD for your next research!! pubmed.ncbi.nlm.nih.gov/3678…

Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real-World...

In 2 independent real-world cohort settings, second-line therapy in CD with ustekinumab after TNF antagonist treatment failure was associated with a lower likelihood of treatment failure than...

pubmed.ncbi.nlm.nih.gov
2
13
2
46
6,051
Please join us in welcoming our new Chief Scientific Officer, @moss_md! Learn more about Dr. Moss here: bit.ly/3EV943b
2
2
48
4,029
Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning arxiv.org/abs/2303.12095

Interpretable histopathology-based prediction of disease relevant...

Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD...

arxiv.org
1
2
238
The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers pubmed.ncbi.nlm.nih.gov/3729…

The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show...

Background: Persistent symptoms in quiescent Crohn's disease (CD) are prevalent and lead to worse outcomes. While changes in the microbial community have been implicated, the mechanisms by which...

pubmed.ncbi.nlm.nih.gov
1
2
236
Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning arxiv.org/abs/2303.12095

Interpretable histopathology-based prediction of disease relevant...

Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD...

arxiv.org
1
2
180
Second–Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real–World Propensity Score–Weighted Analysis - Clinical Gastroenterology and Hepatology (cghjournal.org)
1
32
We asked our community what topic they want to learn about for our next MyIBD Learning webinar, and the results are in! Our next webinar will be Exploring Blood and Stool Tests in IBD. Register here to join us on June 14 at 8 p.m. ET: bit.ly/45Balsq
1
6
2
14
4,260
A new paper was published using SPARC data! academic.oup.com/ibdjournal/…
1
2
212
Clinical Trials Day is May 20! Learn more about our Clinical Trials Community and how you can participate in research here: bit.ly/3BELm9E
5
18
3,356
Excited to share this Request for Information! linkedin.com/posts/benjamin-…

IBD Plexus Request for Information | Benjamin Kostiuk

Excited to share this Request for Information: the Crohn's & Colitis Foundation is looking for partnerships with AI companies to increase the value of our IBD Plexus data with the goal of improving...

linkedin.com
15
Load more